Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 24.76% is 17% below its 5-year average of 29.75%, near the low end of its 5-year range (19.68%–51.11%).
As of the fiscal period ended Sunday, December 28, 2025. 5.77% below its 12-month average of 26.27%.
Annual fiscal-year return on equity; no daily interpolation.
RETURN ON EQUITY (ROE)
24.76%
RETURN ON EQUITY (ROE) AVG TTM
26.27%
RETURN ON EQUITY (ROE) AVG 3Y
31.76%
RETURN ON EQUITY (ROE) AVG 5Y
29.75%
RETURN ON EQUITY (ROE) AVG 10Y
25.16%
RETURN ON EQUITY (ROE) AVG 15Y
23.06%
RETURN ON EQUITY (ROE) AVG 20Y
23.51%
CURRENT VS TTM AVG
-5.77%
CURRENT VS 3Y AVG
-22.03%
CURRENT VS 5Y AVG
-16.76%
CURRENT VS 10Y AVG
-1.60%
CURRENT VS 15Y AVG
+7.37%
CURRENT VS 20Y AVG
+5.31%
SECTOR MEDIAN · HEALTHCARE
10.89%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+127.36%
vs the sector median at left
Johnson & Johnson
Market Cap
$639.90B
Return on Equity (ROE)
24.76%
TTM Avg
26.27%
3Y Avg
31.76%
5Y Avg
29.75%
Market Cap
$143.34B
Return on Equity (ROE)
8.31%
TTM Avg
9.04%
3Y Avg
13.32%
5Y Avg
16.07%
Market Cap
$322.04B
Return on Equity (ROE)
19.48%
TTM Avg
35.83%
3Y Avg
26.05%
5Y Avg
27.71%
Market Cap
$465.69B
Return on Equity (ROE)
13.23%
TTM Avg
-0.29%
3Y Avg
28.74%
5Y Avg
37.53%
Market Cap
$1.14T
Return on Equity (ROE)
81.01%
TTM Avg
76.20%
3Y Avg
64.92%
5Y Avg
71.94%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Johnson & Johnson (JNJ) | $639.90B | 24.76% | 26.27% | 31.76% | 29.75% |
| Pfizer Inc. (PFE)vs › | $143.34B | 8.31% | 9.04% | 13.32% | 16.07% |
| Merck & Co., Inc. (MRK)vs › | $322.04B | 19.48% | 35.83% | 26.05% | 27.71% |
| AbbVie Inc. (ABBV)vs › | $465.69B | 13.23% | -0.29% | 28.74% | 37.53% |
| Eli Lilly and Company (LLY)vs › | $1.14T | 81.01% | 76.20% | 64.92% | 71.94% |
| Bristol-Myers Squibb Company (BMY)vs › | $128.85B | 36.25% | -8.30% | 7.76% | 4.45% |
ROE
24.8%
ROA
10.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-28 | 32.87% |
| 2024-12-29 | 19.68% |
| 2023-12-31 | 51.11% |
| 2023-01-01 | 23.36% |
| 2022-01-02 | 28.20% |
| 2021-01-03 | 23.25% |
| 2019-12-31 | 25.42% |
| 2018-12-31 | 25.60% |
| 2017-12-31 | 2.16% |
| 2016-12-31 | 23.49% |
| 2015-12-31 | 21.66% |
| 2014-12-31 | 23.40% |
| 2013-12-31 | 18.68% |
| 2012-12-31 | 16.74% |
| 2011-12-31 | 16.94% |
| 2010-12-31 | 23.57% |
| 2009-12-31 | 24.25% |
| 2008-12-31 | 30.46% |
| 2007-12-31 | 24.41% |
| 2006-12-31 | 28.11% |
| 2005-12-31 | 25.99% |
| 2004-12-31 | 25.71% |
| 2003-12-31 | 26.79% |
| 2002-12-31 | 29.07% |
| 2001-12-31 | 23.39% |
| 2000-12-31 | 24.29% |
| 1999-12-31 | 26.36% |
| 1998-12-31 | 21.33% |
| 1997-12-31 | 26.73% |
| 1996-12-31 | 26.64% |
